Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial

BACKGROUND: Anastrozole has been associated with substantial accelerated bone mineral density (BMD) loss during active treatment. METHODS: One thousand four hundred and ten women were included in a BMD substudy and stratified into three strata according to their baseline T-score at spine or femoral...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestak, Ivana, Blake, Glen, Patel, Raj, Cuzick, Jack, Howell, Anthony, Coleman, Robert, Eastell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039042/
https://www.ncbi.nlm.nih.gov/pubmed/33495601
http://dx.doi.org/10.1038/s41416-020-01228-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039042/
https://www.ncbi.nlm.nih.gov/pubmed/33495601
http://dx.doi.org/10.1038/s41416-020-01228-2

Ejemplares similares